<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ozawa Y</submitter><funding>Grants-in-Aid for Scientific Research by the Japan Society of the Promotion of Science</funding><pagination>1497</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9099608</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(9)</volume><pubmed_abstract>Retinitis pigmentosa (RP) is a hereditary blinding disease characterized by gradual photoreceptor death, which lacks a definitive treatment. Here, we demonstrated the effect of 4-phenylbutyric acid (PBA), a chemical chaperon that can suppress endoplasmic reticulum (ER) stress, in P23H mutant rhodopsin knock-in RP models. In the RP models, constant PBA treatment led to the retention of a greater number of photoreceptors, preserving the inner segment (IS), a mitochondrial- and ER-rich part of the photoreceptors. Electroretinography showed that PBA treatment preserved photoreceptor function. At the early point, ER-associated degradation markers, &lt;i>xbp1s&lt;/i>, &lt;i>vcp&lt;/i>, and &lt;i>derl1&lt;/i>, mitochondrial kinetic-related markers, &lt;i>fis1&lt;/i>, &lt;i>lc3&lt;/i>, and &lt;i>mfn1&lt;/i> and &lt;i>mfn2&lt;/i>, as well </pubmed_abstract><journal>Cells</journal><pubmed_title>Effects of Epigenetic Modification of PGC-1α by a Chemical Chaperon on Mitochondria Biogenesis and Visual Function in Retinitis Pigmentosa.</pubmed_title><pmcid>PMC9099608</pmcid><funding_grant_id>21K09683</funding_grant_id><pubmed_authors>Ozawa Y</pubmed_authors><pubmed_authors>Okano H</pubmed_authors><pubmed_authors>Homma K</pubmed_authors><pubmed_authors>Tsubota K</pubmed_authors><pubmed_authors>Osada H</pubmed_authors><pubmed_authors>Toda E</pubmed_authors><pubmed_authors>Nagai N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of Epigenetic Modification of PGC-1α by a Chemical Chaperon on Mitochondria Biogenesis and Visual Function in Retinitis Pigmentosa.</name><description>Retinitis pigmentosa (RP) is a hereditary blinding disease characterized by gradual photoreceptor death, which lacks a definitive treatment. Here, we demonstrated the effect of 4-phenylbutyric acid (PBA), a chemical chaperon that can suppress endoplasmic reticulum (ER) stress, in P23H mutant rhodopsin knock-in RP models. In the RP models, constant PBA treatment led to the retention of a greater number of photoreceptors, preserving the inner segment (IS), a mitochondrial- and ER-rich part of the photoreceptors. Electroretinography showed that PBA treatment preserved photoreceptor function. At the early point, ER-associated degradation markers, &lt;i>xbp1s&lt;/i>, &lt;i>vcp&lt;/i>, and &lt;i>derl1&lt;/i>, mitochondrial kinetic-related markers, &lt;i>fis1&lt;/i>, &lt;i>lc3&lt;/i>, and &lt;i>mfn1&lt;/i> and &lt;i>mfn2&lt;/i>, as well </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-25T21:32:54.17Z</modification><creation>2025-02-19T00:55:28.329Z</creation></dates><accession>S-EPMC9099608</accession><cross_references><pubmed>35563803</pubmed><doi>10.3390/cells11091497</doi></cross_references></HashMap>